Quoin Pharmaceuticals Statistics
Total Valuation
QNRX has a market cap or net worth of $710,798. The enterprise value is -$2.11 million.
| Market Cap | 710,798 |
| Enterprise Value | -2.11M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
QNRX has 987,220 shares outstanding. The number of shares has increased by 144.43% in one year.
| Shares Outstanding | 987,220 |
| Shares Change (YoY) | +144.43% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 2.30% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.48 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.15, with zero debt.
| Current Ratio | 3.15 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -105.10% and return on invested capital (ROIC) is -165.58%.
| Return on Equity (ROE) | -105.10% |
| Return on Assets (ROA) | -55.70% |
| Return on Capital (ROIC) | -165.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.17M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.54% in the last 52 weeks. The beta is 1.95, so QNRX's price volatility has been higher than the market average.
| Beta (1Y) | 1.95 |
| 52-Week Price Change | -87.54% |
| 50-Day Moving Average | 1.64 |
| 200-Day Moving Average | 4.14 |
| Relative Strength Index (RSI) | 21.53 |
| Average Volume (30 Days) | 619,969 |
Short Selling Information
The latest short interest is 11,581, so 1.17% of the outstanding shares have been sold short.
| Short Interest | 11,581 |
| Short Previous Month | 33,648 |
| Short % of Shares Out | 1.17% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.47M |
| Pretax Income | -2.29M |
| Net Income | -8.69M |
| EBITDA | -2.26M |
| EBIT | -2.29M |
| Earnings Per Share (EPS) | -$9.64 |
Balance Sheet
The company has $2.82 million in cash and no debt, giving a net cash position of $2.82 million or $2.86 per share.
| Cash & Cash Equivalents | 2.82M |
| Total Debt | n/a |
| Net Cash | 2.82M |
| Net Cash Per Share | $2.86 |
| Equity / Book Value | 1.49M |
| Book Value Per Share | 1.51 |
| Working Capital | 2.03M |
Cash Flow
| Operating Cash Flow | -2.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.07M |
| FCF Per Share | -$2.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -144.43% |
| Shareholder Yield | -144.43% |
| Earnings Yield | -1,222.09% |
| FCF Yield | -291.66% |
Analyst Forecast
The average price target for QNRX is $4.00, which is 455.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 455.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 18, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jul 18, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |